There is also evidence that anti-Gal-9 antibodies promote the expansion of cytotoxic CD8+ cells in a mamary tumor mouse model, reducing a population of tumor-enabling Treg cells (CD4+, Foxp3+, CD25+) (113). Here, CD8A is linked to neoplasm.